Three-component synthesis and antibacterial activity of 5-Aryl-4-acyl-3-hydroxy-1-(4-methoxyphenyl)-3-pyrroline-2-ones

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

A series of new 5-aryl-4-acyl-3-hydroxy-1-(4-methoxyphenyl)-3-pyrrolin-2-ones was synthesized by the reacting of methyl esters of aroylpyruvic acids with a mixture of aromatic aldehyde and p-anisidine. Antibacterial activity of the obtained compounds was studied in vitro against Staphylococcus aureus and Escherichia coli strains.

Texto integral

Acesso é fechado

Sobre autores

N. Kasimova

Perm State Pharmaceutical Academy of the Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: pufmail135@gmail.com
ORCID ID: 0009-0001-6348-7333
Rússia, Perm, 614990

O. Maiamsina

Perm State Pharmaceutical Academy of the Ministry of Health of the Russian Federation; Perm State Medical University named after Academician E. A. Wagner of the Ministry of Health of the Russian Federation

Email: pufmail135@gmail.com
Rússia, Perm, 614990; Perm, 614990

S. Dubrovina

Perm State Pharmaceutical Academy of the Ministry of Health of the Russian Federation

Email: pufmail135@gmail.com
Rússia, Perm, 614990

V. Gein

Perm State Pharmaceutical Academy of the Ministry of Health of the Russian Federation

Email: pufmail135@gmail.com
ORCID ID: 0000-0002-8512-0399
Rússia, Perm, 614990

Bibliografia

  1. Afsah E.M., Abdelmageed S.M. // J. Heterocyclic Chem. 2020. Р. 1. doi: 10.1002/jhet.4098
  2. Manta S., Kollatos N., Mitsos C., Chatzieffraimidi G.-A., Papanastasiou I., Gallos J.K., Komiotis D. // Mini-Rev. Med. Chem. 2020. Vol. 20. N 10. P. 818. doi 10.2174/ 1389557520666200103123114
  3. Гейн О.Н., Рубцова Д.Д., Гейн В.Л. // Хим.-фарм. ж. 2022. Т. 56. № 12. С. 35. doi: 10.30906/0023-1134-2022-56-12-35-37
  4. Cusumano A.Q., Pierce J.G. // Bioorg. Med. Chem. Lett. 2018. Vol. 28. N 16. P. 2732. doi 10.1016/ j.bmcl.2018.02.047
  5. Joksimović N., Petronijević J., Janković N., Baskić D., Popović S., Todorović D., Matic S., Bogdanovic G.A., Vranes M., Tot A., Bugarčić Z. // Bioorg. Chem. 2019. Vol. 88. P. 102954. doi: 10.1016/j.bioorg.2019.102954
  6. Ahankar H., Ramazani А., Slepokura К., Lis Т., Joo S.W. // Green Chem. 2016. N 18. P. 3582. doi: 10.1039/c6gc00157b
  7. Машковский М.Д. Лекарственные средства. М.: Новая волна, 2024. 1216 с.
  8. Paguigan N.D., Yan Y., Karthikeyan M., Chase K., Carter J., Leavitt L.S., Lim A.L., Lin Z., Memon T., Christensen S., Bentzen B.H., Schmitt N., Reilly C.A., Teichert R.W., Raghuraman S., Olivera B.M., Schmidt E.W. // ACS Chem. Biol. 2021. Vol. 16. N 9. P. 1654. doi: 10.1021/acschembio.1c00328
  9. Duncan L.F., Wang G., Ilyichova O.V., Dhouib R., Totsika M., Scanlon M.J., Heras B., Abbott B.M. // Bioorg. Med. Chem. 2021. Vol. 45. P. 116315. doi 10.1016/ j.bmc.2021.116315
  10. Brown D.W., Denman C., OʼDonnell H. // J. Chem. Soc. (C). 1971. P. 3195. doi: 10.1039/J39710003195
  11. Ma K., Wang P., Fu W., Wan X., Zhou L., Chu Y., Ye D. // Bioorg. Med. Chem. Lett. 2011. Vol. 21. N 22. P. 6724. doi: 10.1016/j.bmcl.2011.09.054
  12. Gein V.L., Chalkov D.V., Romanova A.V., Bobrovskaya O.V., Chashchina S.V., Dmitriev M.V. // Russ. J. Org. Chem. 2025. Vol. 61. N 1. P. 16. doi: 10.1134/S1070428025010026
  13. Гейн В.Л., Гейн Л.Ф., Безматерных Э.Н., Шуров С.Н. // ЖОХ. 2000. Т. 70. Вып. 10. С. 1692.
  14. Руководство по проведению доклинических исследований лекарственных средств / Под ред. А.Н. Миронова. М.: Гриф и К, 2012. Ч. 1. 944 с.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
2. Scheme 1. R1 = ОEt, R2 = 4-Br (1); R1 = ОEt, R2 = 4-NO2 (2); R1 = Cl, R2 = H (3); R1 = NO2, R2 = H (4); R1 = ОEt, R2 = 3-NO2 (5); R1 = ОEt, R2 = 2-F (6); R1 = ОEt, R2 = H (7); R1 = NO2, R2 = 2,4-(MeO)2 (8); R1 = ОEt, R2 = 2-NO2 (9); R1 = ОEt, R2 = 4-MeO (10).

Baixar (489KB)
3. Scheme 2.

Baixar (576KB)
4. Scheme 3.

Baixar (600KB)

Declaração de direitos autorais © Russian Academy of Sciences, 2025